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To the Editor,
Postma et al. [1] have compared radioguided occult lesion
localization (ROLL) with wire-guided localization (WGL)
in patients with non-palpable invasive breast carcinoma
requiring surgery with sentinel node biopsy in a multicenter
randomized controlled trial. Three hundred and fourteen
patients were enrolled; 162 were allocated to ROLL and 152
to WGL. Primary outcome measures were the proportion of
complete tumor excisions, the proportion of patients
requiring re-excision and the volume of tissue removed.
They concluded that the two procedures are comparable in
terms of complete tumor excision and re-excision rates, but
ROLL leads to the excision of larger tissue volumes and
cannot replace WGL as the standard of care.
In our opinion, the authors committed at least three
mistakes that make their work less reliable . First of all they
used 99mTc-nanocolloid (99mTc-NC) as radiotracer for
ROLL procedure. This is a comprehensible choice, as a
single injection allowed the localization of non-palpable
breast lesion and the identification of sentinel lymph node,
but not the most effective one.
The ROLL technique was introduced in 1997 at the
European Institute of Oncology in Milan [2]. After the first
experience, which proved that this procedure allowed
rapid, easy, and accurate removal of occult breast lesions
[3–6], the optimal lymphoscintigraphic method to detect
both occult lesions and sentinel node (that was called
SNOLL: sentinel node and occult lesion localization) was
evaluated [7]. Two hundred and twenty-seven patients with
non-palpable breast lesions were enrolled in the study. One
hundred and forty-eight patients were submitted to the
ROLL procedure using macroaggregates of 99mTc-labelled
human serum albumin (99mTc-MAA) injected directly into
the lesion and also to lymphoscintigraphy with 99mTc-NC
injected in peritumoral (62 patients) and subdermal site (86
patients). Seventy-nine patients received only an intratu-
moral injection of 99mTc-NC to perform both ROLL and
sentinel node localization. The results showed that ROLL
has a high rate of success (94.7 %), without significant
differences among the groups. These findings demonstrated
that NC may be used for lesion localization, but in some
cases the surgeons had difficulties in delimiting the exact
edge of the hot spot. This was probably due to the NC
migration to the lymphatic vessels in the patients submitted
to the single injection. On the contrary, MAA do not move
from the injection site: consequently they do not adversely
affect the radioguided tumor excision and do not determine
an increase of the quantity of healthy tissue removed, as
probably occurred in Postma et al. patients.
Other two factors that we believe may have affected the
results are the excessive volume and amount of injected
radiotracer. Indeed, the authors performed an intratumoral
injection of 120 MBq of 99mTc-NC in a volume of max
0.5 ml of saline and this could have contributed to the
excision of a larger volume of tissue. In our previous papers,
we used an amount of radiotracer 12–30 times as small as
Postma’s one (from 3.7 to 7–10 MBq) in only 0.2 ml of
saline [3–7], obtaining excellent results (that were recon-
firmed on more than nine hundred patients submitted to the
SNOLL procedure from 1997 to 2004 [8]) and implying
negligible radiation risk for patients and medical staff [9].
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Finally, an important factor to be taken into account is
that, through ROLL procedure, the exact site of the
radiolabelled lesion can be checked at any time with the
gamma probe during the operation. The surgeon can then
determine the best incision to reach the lesion, regardless
of the site of radiotracer injection. In this way a portion of
breast tissue containing the lesion at its centre can be
removed, guaranteeing oncological radicality and also
avoiding excessive mutilation [3, 4].
After all, the ROLL procedure with direct injection of
99mTc-MAA into the lesion is easy, safe, and accurate and
it can be performed in association with subdermal injec-
tion of 99mTc-NC for sentinel node detection without
interference. From 1999 it represents the method of choice
for accurate localization of non-palpable breast lesion in
our institution, where it has been invented and performed,
alone or as SNOLL, in nearly 10,000 patients (Paganelli G,
Veronesi U, personal communication).
Last but not least, the technique and acronym ROLL
although not registered was pioneered at IEO in 1996 and
should be used as originally described [2–4]. What the so-
called ‘‘ROLL study group’’ have done is certainly some-
thing different from the ‘‘original’’ ROLL technique
described by our group.
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Reply to: Improper use of ‘‘radioguided occult lesion localization’’
(ROLL) technique leads to misleading conclusions
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R. van Hillegersberg
To the Editor,
In a reply to our previously published paper in which we
compared ROLL with WGL, Paganelli et al., question the
reliability of our results. First, they state that the use of
technetium nanocolloid could have caused the increase of
the excised tissue volumes in the ROLL group as nano-
colloid can migrate into the lymphatic vessels. Indeed, we
used 99Tc-nanocolloid as this offers the opportunity to
combine the radioguided lesion detection with the sentinel
node procedure in a single injection. We consider this as
the most important advantage of the ROLL procedure and
therefore we included only breast cancer patients that
would have to undergo a sentinel node procedure. In our
trial, the gamma probe was used first to identify the sen-
tinel node, followed by the site of the maximum count rate
in the breast. The surgeon excised the breast tissue around
this puntum maximum while taking the size and imaging
characteristics of the tumour into consideration. The surgeon
did not use a fall of radioactivity for determining the size of
the excised specimen. For this reason we feel that migration
of the nanocolloid could not have affected our results.
In addition, Paganelli et al. suggest that the volume and
amount of injected radiotracer used in our study could have
affected our results. In our study we used a radiotracer
injection with a dosage of 120 MBq 99mTc-nanocolloid.
This is a higher dosage than used and mentioned by Pa-
ganelli (3.7–10 MBq). In the past it has been demonstrated
that a higher tracer dosage leads to an improved sentinel
node identification rate [1]. For this reason we chose to use
this higher amount of MBq. In the past, others have used a
dosage of 123–130 MBq, demonstrating good results with
regard to detection of both the tumour as the sentinel node
[2, 3].
Regarding the volume of the injected radiotracer; we
used a volume of max 0.5 ml, this is 0.1–0.3 ml more than
used in studies mentioned by Paganelli. We believe that
this very small difference in volume could not have been of
much influence on the excision volumes. Also, the amount
of tissue excised was determined by the site of the radio-
active hot spot and the mammographic tumour size.
Paganelli et al. did not mention the amount of tissue
excised in their cohort of patients. It would be interesting to
publish these to compare the results with our results. Maybe,
their results are actually quite similar to ours. And as dis-
cussed in our paper, another explanation for the absence of
superiority of ROLL over WGL found in our study could be
related to the very good results obtained with WGL.
Finally, it is important to realise that our study is the first
well set-up RCT comparing ROLL with WGL. Paganelli
et al. did not perform a comparative study.
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